The Video Journal of Hematology and Hematological Oncology / X
Jul 19, 2025, 19:00
Steven Treon on Promising Advances: 3 Novel Therapies Transforming Waldenström’s Macroglobulinemia
The Video Journal of Hematology and Hematological Oncology shared a post on X:
”What are some of the most exciting developments in the field of Waldenström’s macroglobulinemia? We caught up with Steven Treon of Dana-Farber Cancer Institute at 18 ICML to find out!”
Watch the interview here.
Dr. Steven Treon highlights promising advances in Waldenström’s macroglobulinemia, focusing on novel therapies like BTK degraders, that demonstrate strong efficacy, even in resistant cases, as well as non-covalent BTK inhibitors and BCL2 inhibitors.
His insights were shared at the 18th International Conference on Malignant Lymphoma in Lugano.
Latest scientific advancements in hematology highlighted in Hemostasis Today.
-
May 22, 2026, 13:41Ney Carter Borges: New Trial Highlights IVL as Effective Strategy for Calcified Coronary Lesions
-
May 22, 2026, 13:36Ajay Samkaria։ A Compatible Crossmatch Does Not Always Mean Complete Safety
-
May 22, 2026, 13:31Mariam Swidan: Why Hemolysis Severity Matters in G6PD Deficiency
-
May 22, 2026, 13:25Augustina Isioma Ikusemoro: Why Plasma and RBC Transfusions Follow Different Compatibility Rules
-
May 22, 2026, 13:08Anas Hamad: Thrombosis as Overlooked Clinical Challenge in APL
-
May 22, 2026, 12:29Neema Ngugi: Highlighting 6 Major Types of Anemia
-
May 22, 2026, 12:27Jacinto López Sagaseta: Solving the Structural Puzzle of FVIIa–EPCR Interaction
-
May 22, 2026, 12:25Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms
-
May 22, 2026, 11:52Prakash W. Kamat: Highlighting the Role of Physical Activity in Hemophilia Management